HeartBeam Expands Patent Portfolio with Innovative Cardiac Monitoring Technologies
Medical technology company HeartBeam adds two new U.S. patents to its intellectual property collection, enhancing its capabilities in portable cardiac monitoring and arrhythmia detection technology.
HeartBeam Inc. has significantly strengthened its intellectual property position with the issuance of two new U.S. patents, bringing its total issued patent count to 20 with an additional 34 patents pending or allowed. The new patents focus on advanced cardiac monitoring technologies that could transform how patients track and manage heart health.
The first patent covers a credit card-sized, cable-free 3D ECG device capable of real-time cardiac monitoring and symptom capture. This innovative technology enables patients to collect comprehensive heart data outside traditional medical settings. The second patent protects a sophisticated rhythm analysis algorithm designed to identify arrhythmias through continuous signal input, proactively alerting users to potential cardiac anomalies.
These technological advancements represent a significant step towards personalized, portable cardiac care. By developing devices that can detect and analyze heart rhythms in real-time, HeartBeam is positioning itself at the forefront of remote health monitoring. The patents complement the company's ongoing efforts to develop a 12-lead ECG synthesis software currently under FDA review.
The expanded patent portfolio not only demonstrates HeartBeam's commitment to innovation but also provides a strong intellectual property foundation for future product development. As healthcare continues to shift towards more personalized and accessible monitoring technologies, HeartBeam's advances could play a crucial role in early cardiac condition detection and management.